A Study of Genetic Variation Influencing Pain and Response to Opioid Medications

NCT01293994 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-11-22

No results posted yet for this study

Summary

The investigators will be collecting saliva DNA samples from chronic back pain patients. The investigators hope to find candidate genes associated with response to opioid medication by correlating molecular genetics data with pain measurement and opioid responsiveness data including opioid hyperalgesia and opioid analgesic tolerance.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Dr Larry Fu-nien Chu · Stanford University

Eligibility

Min Age
18 Years
Max Age
71 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01293994 on ClinicalTrials.gov